As of Jul 02
| -0.07 / -0.14%|
The 13 analysts offering 12-month price forecasts for CSPC Pharmaceutical Group Ltd have a median target of 58.04, with a high estimate of 70.94 and a low estimate of 48.80. The median estimate represents a +17.40% increase from the last price of 49.44.
The current consensus among 13 polled investment analysts is to Buy stock in CSPC Pharmaceutical Group Ltd. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.